Life Spine Gains FDA Clearance for Additions to ARx

By Julie A. Vetalice

Life Spine Gains FDA Clearance for Additions to ARx

Life Spine was granted FDA 510(k) clearance to market implant and instrument additions to the ARx Spinal System. ARx received its original clearance in 2006; this is the system's fourth clearance update.

ARx is Life Spine's fourth 510(k) clearance in 2020, marking 92 clearances for the company overall. ARx is complemented by the PROLIFT® Expandable System and can be utilized with the SOLSTICE® Occiptio-Cervico-Thoracic System of hooks, prebent rods, transition components, cross connectors, etc.

“The additions to the ARx Spinal System will allow us to provide surgeons with the tools to accommodate a larger range of complex and deformity spinal procedures,” said Rich Mueller, Chief Operating Officer for Life Spine. “The ARx Spinal System is designed to advance the treatment for spinal deformity patients with a range of unique spinal implants and intuitive instrumentation which is consistently being enhanced by our research and development team to meet patient needs.”

Product Labels: Spinal Fusion

Tags: 510(k) Clearance, Regulatory